tirzepatide safety vs semaglutide safety peptide Balanced Bodies tirzepatide and semaglutide therapeutic modality

Other than in STEP 2, which enrolled patients with type 2 diabetes, patients with a hemoglobin A1C of 6.5% or greater were excluded, as were patients who had a self-reported change in body weight of greater than 5 kg within 90 days of screening

However, when anecdotal reports began to link these medications to increased risk for regurgitation and pulmonary aspiration of gastric contents in patients under anesthesia, anesthesiologists quickly sounded the alarm

Its not a diagnosis just a starting point for self-awareness

Don't double up the next day

[7] [8] Higher doses of semaglutide (available as Wegovy injection) are specifically licensed for weight management and produce more substantial weight loss